Modern approaches to the diagnosis and treatment of diabetic polyneuropathy

• Ekaterina I. Shevkun
• Vsevolod V. Skvortsov

Abstract

Diabetic neuropathy is the most common complication of diabetes mellitus and is characterized by symmetric damage of nerve fibers, usually slow and irreversible progression. Early diagnosis and timely treatment based on blocking the main pathogenetic mechanisms can slow the progression of the disease.

Keywords:diabetic polyneuropathy, pathogenesis, clinical picture, diagnosis, treatment

References

1. World Health Organization. Health topics. Noncommunicable diseases. 2018. URL: https://www.who.int/topics/noncommunicable_dis-eases/ru/

2. IDF Diabetes Atlas. 9th ed. 2019. URL: https://www.diabetesatlas.org/en/ (date of access May 10, 2020)

3. Levin O.S. Diabetic polyneuropathy: current approaches to diagnosis and pathogenetic therapy. Klinitsist [Clinician]. 2013; 7 (2): 54. DOI: https://doi.org/10.17650/1818-8338-2013-7-2-221-235 (in Russian)

4. Khramilin V.N., Demidova I. Yu., Zav’yalov A.N. Painful diabetic polyneuropathy: from clinical guidelines to daily practice. Meditsinskiy sovet [Medical Council]. 2019; (4): 52-60. DOI: https://doi.org/10.21518/2079-701X-2019-4-52-60 (in Russian)

5. Starostina E.G. Diabetic neuropathy: some issues in differential diagnosis and systemic treatment of the pain syndrome. RMZh [Russian Medical Journal]. 2017; (22): 1665-76. (in Russian)

6. Sakovets T.G. Diabetic autonomic neuropathy as a risk factor for emergencies Kazanskiy meditsinskiy zhurnal [Kazan Medical Journal]. 2016; 97 (6): 931-4. DOI: https://doi.org/10.17750/KMJ2016-931 (in Russian)

7. Maksimova N., Moshenina S. Treatment-induced diabetic neuropathy (Ellenberg syndrome). Vrach [Physician]. 2018; 29 (9): 53-7. DOI: https://doi.org/10.29296/25877305-2018-09-12 (in Russian)

8. Stino A.M., Smith A.G. Peripheral neuropathy in prediabetes and the metabolic syndrome. J Diabetes Investig. 2017; 8: 646-55.

9. The DCCT Research Group. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia. 1998; 41: 416-23.

10. Nathan D.M., Genuth S., Lachin J., et al.; Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329: 977-86.

11. Feldman E.L., Nave K.A., Jensen T.S., Bennett D.L.H. New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain. Neuron. 2017; 93: 1296-313.

12. Rivner M.H., Swift T.R., Malik K. Influence of age and height on nerve conduction. Muscle Nerve. 2001; 24: 1134-41.

13. Stetson D.S., Albers J.W., Silverstein B.A., Wolfe R.A. Effects of age, sex, and anthropometric factors on nerve conduction measures. Muscle Nerve. 1992; 15: 1095-104.

14. Tesfaye S., Chaturvedi N., Eaton S.E., et al.; EURODIAB Prospective Complications Study Group. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005; 352: 341-50.

15. Ziegler D. Treatment of diabetic neuropathy and neuropathic pain. Diabetes Care. 2008; 31 (suppl 2): S 255-61.

16. Nedosugova L.V. Pathogenesis, clinical manifestations and treatment approaches for diabetic polyneuropathy. Meditsinskiy sovet [Medical Council]. 2013; (12): 43-9. DOI: https://doi.org/10.21518/2079-701X-2013-12-43-49 (in Russian)

17. Ryle C., Donaghy M. Non-enzymatic glycation of peripheral nerve proteins in human diabetics. J Neurol Sci. 1995; 129: 62.

18. Dyck PJ., Albers J.W., Andersen H., et al.; Toronto Expert Panel on Diabetic Neuropathy. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev. 2011; 27 (7): 620-8.

19. Ametov A.S., Milovanova O.A., Prudnikova M.A., Depyui T.I. Diabetic neuropathy in patients with type 2 diabetes: role of chronic inflammation. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2016; 2 (15): 52-8. (in Russian)

20. Sugimoto K., Yasujima M., Yagihashi S. Role of advanced glycation end products in diabetic neuropathy. Curr Pharm Des. 2008; 14 (10): 953-61.

21. Spasov A.A., Solov’eva O.A., Kuznetsova V.A., Protein glycation during diabetes mellitus and possibility of its pharmacological correction (a review). Khimiko-farmatsevticheskiy zhurnal [Pharmaceutical Chemistry Journal]. 2017; 51 (6): 3-7. DOI: https://doi.org/10.30906/0023-1134-2017-51-6-3-7 (in Russian)

22. Demidova I. Yu., Khramilin V.N., Ignatova O. Yu. Distal diabetic neuropathy Endokrinnaya khirurgiya [Endocrine Surgery]. 2008; 1 (2): 29-39. (in Russian)

23. Vertkin A.L., Danilov A.B., Mkrtumyan A.M. Consensus on management of diabetic neuropathy in general practice (Approved by the Council of experts on 8 April 2017). Ambulatorniy priyom [Outpatient Appointments]. 2017; 2 (8): 32-6. (in Russian)

24. Fokina A.S., Strokov I.A., Demura T.A. Diagnosis of diabetic peripheral neuropathy. Methods of its early detection. RMZh [Russian Medical Journal]. 2017; (9): 572-8. (in Russian)

25. Bretzel R. Intensive insulin regimens: evidence for benefit. Int J Obes Relat Metab Disord. 2004; 28 (suppl 2): 8-13.

26. Anikeeva O. Yu. Possibility of using quantitative sensory testing in evaluation of neuropathy in patients with metabolic syndrome. Vrach-as-pirant [Postgraduate Doctor]. 2013; 6 (61): 77-84. (in Russian)

27. Kotov A.S. diabetic polyneuropathy: a review. Effektivnaya farma-koterapiya. Endokrinologiya [Effective Pharmacotherapy. Endocrinology]. 2011; (5): С. 44-50. (in Russian)

28. Starostina E.G. Diabetes mellitus and mental disorders. In: I.I. Dedov, M.V. Shestakova (eds). Diabetes Complications: Treatment and Prevention. Moscow: Meditsinskoe informatsionnoe agentstvo, 2017: 70543. (in Russian)

29. Krasavina M., Astakhov Yu.S., Shadrichev F.E. Could corneal con-focal microscopy assess nerve fiber damage in patients with diabetic polyneuropathy? Oftal’mologicheskie vedomosti [Ophthalmological Statements]. 2012; (3): 15-8. (in Russian)

30. Malik R., Kallinikos P., Abbott C., et al. Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia. 2003; 46: 683-8.

31. Kotova O.V., Akarachkova E.S. Diabetic autonomic polyneuropathy. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Korsakov’s Journal of Neurology and Psychiatry]. 2017; (2): 169-73. (in Russian)

32. Ziegler D., Hanefild M., Ruhnau K., et al.; The ALADIN III Study Group. Treatment of symptomatic diabetic polyneuropathy with the anti-oxydant alfa-lipoic acid. A 3 week multicenter randomized controlled trial. Diabetes Care. 1999; 22: 1296-301.

33. Reljanovic M., Reichel G., Lobisch M., et al. Treatment of diabetic polyneuropathy with the antioxydant thioctic acid (alfa-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II) Alfa-lipoic acid in diabetic neuropathy. Free Radic. Res. 1999; 31: 171-9.

34. Gomes M.B., Negrato C.A. Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases. Diabetol Metab Syndr. 2014; 6: 80.

35. Strokov I.A., Fokina F.S., Zilov F.V. Actovegin in treatment of neurological complications in diabetes mellitus. Effektivnaya farmakoterapiya. Endokrinologiya [Effective Pharmacotherapy. Endocrinology]. 2015; 43 (5): 20-7. (in Russian)

36. Molina М., Gonzalez R., Folgado J., Real J.T., et al. Correlation between plasma concentrations of homocysteine and diabetic polyneuropathy evaluated with the Semmes-Weinstein monofilament test in patients with type 2 diabetes mellitus. Med Clin (Barc). 2013; 141 (9): 382-6.

37. Li J., Shi M., Zhang H., Yan L., et al. Relation of homocysteine to early nephropathy in patients with Type 2 diabetes. Clin Nephrol. 2012; 77 (4): 305-10.

38. Mokhort T.V. Vitamin B 12 in diabetes: a systematic review and rationale for use. Meditsinskie novosti [Medical News]. 2019; (10): 4-8. (in Russian)

39. Koshel’ L.V., Romatsova T.I. The role of phenofibrate in the treatment of microvascular complications of type 2 diabetes mellitus. Sakharniy diabet [Diabetes Mellitus]. 2009; (4): 99-103. (in Russian)

40. Marx N., Kehrle B., Kohlhammer K., et al. PPAR activators as antiinflammatory mediators in human T lymphocytes. Implications for atherosclerosis and transplantation-associated arteriosclerosis. Circ Res. 2002; 90: 703-10.

41. Davis T.M.E., Yeap B.B., Davis W.A., Bruce D.G. Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study. Diabetologia. 2008; 51: 562-6.

42. Zus’man A.A., Turbina L.G., Gordeev S.A. Treatment of painful diabetic neuropathy. Lechashchiy vrach [Attending Physician]. 2011; (3): 12-5/ (in Russian)

43. Bril V., England J., Franklin G.M., et al. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2011; 76 (20): 1758-65. DOI: https://doi.org/10.1212/WNL.0b013e3182166ebe

44. Ogata K., Masaki T., Takao F., Kunimoto M., Inoue K. Therapeutic trials with topical capsaicin cream and iontophoretically applied lidocaine for diabetic painful truncal neuropathy. Rinsho Shinkeigaku. 1996; 36 (1): 30-3. URL: http://www.ncbi.nlm.nih.gov/pubmed/8689786

45. Vesovic-Potic V., Conic S. Use of pulsating high-frequency electromagnetic fields in patients with diabetic neuropathies and angiopathies. Srp Arh Celok Lek. 1993; 121 (8-12): 124-6. URL: http://www.ncbi.nlm.nih.gov/pubmed/7725151

46. Yamany A.A., Sayed H.M. Effect of low level laser therapy on neurovascular function of diabetic peripheral neuropathy. J Adv Res. 2012; 3 (1): 21-8.

47. Chatchawan U., Eungpinichpong W., Plandee P., Yamauchi J. Effects of Thai foot massage on balance performance in diabetic patients with peripheral neuropathy: a randomized parallel-controlled trial. Med Sci Monit Basic Res. 2015; 21: 68-75.

48. Garrow A.P., Xing M., Vere J., Verrall B., Wang L., Jude E.B. Role of acupuncture in the management of diabetic painful neuropathy [DPN]: a pilot RCT. Acupunct Med. 2014; 32 (3): 242-9.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)